| CXSL2101123 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | New Drug Application | 2021-06-08 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | | | view |
| CYSB2200110 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(1) | Supplementary Application | 2022-04-27 | | BeiGene Guangzhou Biologics Manufacturing Co Ltd;Boehringer Ingelheim Biopharmaceuticals (China) Ltd | | | view |
| CXSL2300534 | 替雷利珠单抗注射液（皮下注射） | tislelizumab | Injection | Biological Products(2.1) | New Drug Application | 2023-08-02 | | BeiGene Guangzhou Biologics Manufacturing Co Ltd | | | view |
| CXSB2101058 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | Supplementary Application | 2021-11-10 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | | | view |
| CXSS2400013 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | New Drug Application | 2024-01-19 | | BeiGene Guangzhou Biologics Manufacturing Co Ltd;Boehringer Ingelheim Biopharmaceuticals (China) Ltd | | | view |
| CXSL2101047 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | New Drug Application | 2021-04-28 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | | | view |
| CXSS2200095 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | New Drug Application | 2022-12-31 | | BeiGene Guangzhou Biologics Manufacturing Co Ltd;Boehringer Ingelheim Biopharmaceuticals (China) Ltd | | | view |
| CXSB2200084 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products | Supplementary Application | 2022-10-26 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd;Boehringer Ingelheim Biopharmaceuticals (China) Ltd | | | view |
| CYSB2400312 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(1) | Supplementary Application | 2024-12-04 | | BeiGene Guangzhou Biologics Manufacturing Co Ltd;Boehringer Ingelheim Biopharmaceuticals (China) Ltd | | | view |
| CXSS2200075 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | New Drug Application | 2022-08-23 | | BeiGene Guangzhou Biologics Manufacturing Co Ltd;Boehringer Ingelheim Biopharmaceuticals (China) Ltd | | | view |
| CYSB2200094 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products | Supplementary Application | 2022-03-21 | | BeiGene Guangzhou Biologics Manufacturing Co Ltd;Baiji Shenzhou (Shanghai) Biotechnology Co Ltd;Boehringer Ingelheim Biopharmaceuticals (China) Ltd | | | view |
| CXSS2101021 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | New Drug Application | 2021-08-20 | | BeiGene Guangzhou Biologics Manufacturing Co Ltd;Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | | | view |
| CXSB2300077 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | Supplementary Application | 2023-08-01 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd;Boehringer Ingelheim Biopharmaceuticals (China) Ltd | | | view |
| CXSL2200060 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | New Drug Application | 2022-01-29 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | | | view |
| CYSB2300230 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(1) | Supplementary Application | 2023-12-09 | | BeiGene Guangzhou Biologics Manufacturing Co Ltd;Boehringer Ingelheim Biopharmaceuticals (China) Ltd | | | view |
| CXSL2101060 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | New Drug Application | 2021-05-11 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | | | view |
| CXSB2200046 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | Supplementary Application | 2022-05-24 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | | | view |
| CYSB2400264 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(1) | Supplementary Application | 2024-09-29 | | BeiGene Guangzhou Biologics Manufacturing Co Ltd;Boehringer Ingelheim Biopharmaceuticals (China) Ltd | | | view |
| CXSL2200360 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | New Drug Application | 2022-08-05 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | | | view |
| CYSB2200290 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(1) | Supplementary Application | 2022-12-27 | | BeiGene Guangzhou Biologics Manufacturing Co Ltd;Boehringer Ingelheim Biopharmaceuticals (China) Ltd | | | view |
